Edwards Lifesciences Corporation Proceeds from Collection of Notes Receivable
Edwards Lifesciences Corporation (EW) reported Proceeds from Collection of Notes Receivable of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromCollectionOfNotesReceivable · last filed 2025-02-28
- Edwards Lifesciences Corporation proceeds from collection of notes receivable for the quarter ending 2023-12-31 was $0.00.
- Edwards Lifesciences Corporation proceeds from collection of notes receivable for the quarter ending 2023-09-30 was $0.00.
- Edwards Lifesciences Corporation proceeds from collection of notes receivable for the quarter ending 2023-06-30 was $0.00.
- Edwards Lifesciences Corporation proceeds from collection of notes receivable for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- Edwards Lifesciences Corporation proceeds from collection of notes receivable for fiscal 2024 was $0.00.
- Edwards Lifesciences Corporation proceeds from collection of notes receivable for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Edwards Lifesciences Corporation proceeds from collection of notes receivable for fiscal 2022 was $18.00M, a 10.00% decline from fiscal 2021.
- Edwards Lifesciences Corporation proceeds from collection of notes receivable for fiscal 2021 was $20.00M.
| Period end | Proceeds from Collection of Notes Receivable 3 month | Proceeds from Collection of Notes Receivable 6 month | Proceeds from Collection of Notes Receivable 9 month | Proceeds from Collection of Notes Receivable 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-28 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $0.00 derived: sum of 2 quarters · filed 2025-02-28 | $0.00 derived: sum of 3 quarters · filed 2025-02-28 | $0.00 10-K · filed 2025-02-28 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | $0.00 derived: sum of 2 quarters · filed 2023-10-27 | $0.00 10-Q · filed 2023-10-27 | $0.00 derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $0.00 10-Q · filed 2023-07-28 | $0.00 derived: sum of 3 quarters · filed 2025-02-28 | $0.00 derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $0.00 10-Q · filed 2023-04-28 | $0.00 derived: sum of 2 quarters · filed 2025-02-28 | $0.00 derived: sum of 3 quarters · filed 2025-02-28 | $0.00 derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $0.00 derived: sum of 2 quarters · filed 2025-02-28 | $0.00 derived: sum of 3 quarters · filed 2025-02-28 | $18.00M 10-K · filed 2025-02-28 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | $0.00 derived: sum of 2 quarters · filed 2023-10-27 | $18.00M 10-Q · filed 2023-10-27 | $28.00M derived: sum of 4 quarters · filed 2024-02-12 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $18.00M 10-Q · filed 2023-07-28 | $28.00M derived: sum of 3 quarters · filed 2024-02-12 | $28.00M derived: sum of 4 quarters · filed 2024-02-12 |
| 2022-03-31 | $18.00M 10-Q · filed 2023-04-28 | $28.00M derived: sum of 2 quarters · filed 2024-02-12 | $28.00M derived: sum of 3 quarters · filed 2024-02-12 | $38.00M derived: sum of 4 quarters · filed 2024-02-12 |
| 2021-12-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-12 | $10.00M derived: sum of 2 quarters · filed 2024-02-12 | $20.00M derived: sum of 3 quarters · filed 2024-02-12 | $20.00M 10-K · filed 2024-02-12 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $10.00M derived: sum of 2 quarters · filed 2022-10-28 | $10.00M 10-Q · filed 2022-10-28 | $10.00M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-06-30 | $10.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-29 | $10.00M 10-Q · filed 2022-07-29 | $10.00M derived: sum of 3 quarters · filed 2023-02-13 | $10.00M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-03-31 | $0.00 10-Q · filed 2022-04-28 | $0.00 derived: sum of 2 quarters · filed 2023-02-13 | $0.00 derived: sum of 3 quarters · filed 2023-02-13 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-13 | $0.00 derived: sum of 2 quarters · filed 2023-02-13 | $0.00 10-K · filed 2023-02-13 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $0.00 10-Q · filed 2021-10-29 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-07-30 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |